European Journal of Medicinal Chemistry p. 65 - 73 (2017)
Update date:2022-07-30
Topics:
Park, Dong-Sik
Jo, Eunji
Choi, Jihyun
Lee, MyungEun
Kim, Soohyun
Kim, Hee-Young
Nam, Jiyon
Ahn, Sujin
Hwang, Jong Yeon
Windisch, Marc Peter
Upon high-throughput screening of synthetic small molecule libraries with the infectious hepatitis C virus (HCV) cell culture system, we identified an iminodipyridinopyrimidine (IDPP) scaffold. IDPP did not inhibit HCV replication, but exhibited very potent inhibitory activity on early and late steps of HCV life cycle. Applying an intensive structure-activity relationship (SAR) study, a promising IDPP Lead compound (12c) with excellent potency (EC50 = 10 nM), high safety margin (SI > 2000), and an acceptable stability in human and rat liver microsomes (t1/2 >60 min) was identified. Overall, our results suggest that the IDPP scaffold could be used for the development of novel HCV interventions.
View MoreXiamen Goodhealth Pharmchem Co., Ltd.
Contact:0086-592-2097683
Address:404R No.2 54# Minzu Rd., Xiamen, China
Zipont chem(wuhan)Tech co.,Ltd
Contact:+86-27-87587198
Address:wuhan
LinHai Cina Chemical Co., LTD.
Contact:0576-85580989
Address:Pharma-chem zone,Duqiao,Linhai,Zhejiang,China
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
Contact:+86-575-82733999 0575-82732999
Address:hangzhou gulf fine chemical zone,shangyu city,zhejiang province
Doi:10.1055/s-0030-1260009
(2011)Doi:10.1134/S1070428011060133
(2011)Doi:10.1021/ol102994q
(2011)Doi:10.1016/S0957-4166(00)80072-5
(1993)Doi:10.1016/S0040-4039(00)89312-0
(1985)Doi:10.1021/om970769t
(1998)